BTCY (Biotricity) Cyclically Adjusted FCF per Share: $-1.25 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BTCY Biotricity Inc BTCY
20 GF Score
Price $0.11
GF Value $0.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Biotricity Cyclically Adjusted FCF per Share?

Biotricity BTCY -0.18% 20 Cyclically Adjusted FCF per Share is $-1.25 as of Mar. 2026. GuruFocus rates BTCY with a GF Score™ of 20/100 and a GF Value™ of $0.39 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biotricity's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-1.25 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-19), Biotricity's current stock price is $0.1128. Biotricity's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-1.25. Biotricity's Cyclically Adjusted Price-to-FCF of today is .


Biotricity  (OTCPK:BTCY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biotricity Cyclically Adjusted FCF per Share Related Terms


Biotricity Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Biotricity's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotricity Cyclically Adjusted FCF per Share Chart

Biotricity Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.26 -1.25

Biotricity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.26 -1.24 -1.25 -1.24 -1.25

BTCY vs FEED, LUDG, USAQ: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Biotricity's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotricity Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotricity's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biotricity's Cyclically Adjusted Price-to-FCF falls into.


BTCY
20GF Score
Biotricity Inc BTCY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotricity Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biotricity's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.001/330.2130*330.2130
=-0.001

Current CPI (Mar. 2026) = 330.2130.

Biotricity Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.138 241.018 -0.189
201609 -0.149 241.428 -0.204
201612 -0.135 241.432 -0.185
201703 -0.246 243.801 -0.333
201706 -0.280 244.955 -0.377
201709 -0.181 246.819 -0.242
201712 -0.200 246.524 -0.268
201803 -0.370 249.554 -0.490
201806 -0.227 251.989 -0.297
201809 -0.267 252.439 -0.349
201812 -0.247 251.233 -0.325
201903 -0.199 254.202 -0.259
201906 -0.225 256.143 -0.290
201909 -0.246 256.759 -0.316
201912 -0.351 256.974 -0.451
202003 -0.487 258.115 -0.623
202006 -0.391 257.797 -0.501
202009 -0.345 260.280 -0.438
202012 -0.479 260.474 -0.607
202103 -0.551 264.877 -0.687
202106 -0.411 271.696 -0.500
202109 -0.453 274.310 -0.545
202112 -0.548 278.802 -0.649
202203 -0.564 287.504 -0.648
202206 -0.471 296.311 -0.525
202209 -0.515 296.808 -0.573
202212 -0.366 296.797 -0.407
202303 -0.215 301.836 -0.235
202306 -0.209 305.109 -0.226
202309 -0.272 307.789 -0.292
202312 -0.145 306.746 -0.156
202403 -0.124 312.332 -0.131
202406 -0.105 314.175 -0.110
202409 -0.018 315.301 -0.019
202412 -0.004 315.605 -0.004
202503 -0.015 319.799 -0.015
202506 -0.014 322.561 -0.014
202509 0.016 324.800 0.016
202512 -0.027 324.054 -0.028
202603 -0.001 330.213 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-1.25 mean?
Biotricity (BTCY) has a Cyclically Adjusted FCF per Share of $-1.25 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biotricity and its competitors.
Is Biotricity's Cyclically Adjusted FCF per Share too high?
Biotricity's current Cyclically Adjusted FCF per Share is $-1.25. Overall, Biotricity has a GF Score™ of 20/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biotricity's Cyclically Adjusted FCF per Share compare to FEED and LUDG?
Biotricity's Cyclically Adjusted FCF per Share of $-1.25 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biotricity and its competitors. Biotricity's current Cyclically Adjusted FCF per Share is $-1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotricity stock overvalued right now?
Based on GuruFocus' analysis, Biotricity (BTCY) is currently considered Possible Value Trap. The stock's GF Value™ is $0.39, compared to a current price of $0.11 — trading 71.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-1.25. Biotricity's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Biotricity (BTCY), the current Cyclically Adjusted FCF per Share is $-1.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biotricity (BTCY) Overvalued in 2026?

Based on GuruFocus' analysis, Biotricity stock appears to be undervalued. The current stock price of $0.11 is trading 71.1% below its estimated GF Value™ of $0.39. GuruFocus considers Biotricity to be Possible Value Trap.

Key valuation signals for BTCY:

  • Cyclically Adjusted FCF per Share: $-1.25
  • GF Value™: $0.39 vs. price of $0.11 (71.1% below fair value)
  • GF Score™: 20/100 with 7 warning signs

No single metric tells the full story. See the BTCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biotricity Business Description

Address 203 Redwood Shores Parkway, Suite 600, Redwood City, CA, USA, 94065
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.
20GF Score

Get the complete analysis for BTCY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.39
GF Value